ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 08/13/2025 at 18:00, 10 months 9 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre total de droits de vote et d'actions conformément à la réglementation en vigueur. Abivax se focalise sur le développement de traitements thérapeutiques pour les maladies inflammatoires chroniques

Droits De Vote Actions Abivax Traitements Thérapeutiques Maladies Inflammatoires
PRESS RELEASE

published on 08/13/2025 at 18:00, 10 months 9 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
ABIVAX communique le nombre d'actions composant son capital social et le nombre total de droits de vote conformément aux dispositions réglementaires

Droits De Vote Capital Social Abivax Finance Réglementaire
BRIEF

published on 07/28/2025 at 22:20, 10 months 24 days ago

Abivax Completes $747.5 Million Public Offering

Biotechnology Abivax Ulcerative Colitis Nasdaq Public Offer
BRIEF

published on 07/28/2025 at 22:20, 10 months 24 days ago

Abivax conclut une offre publique de 747,5 millions de dollars

Biotechnologie Abivax Nasdaq Rectocolite Hémorragique Offre Publique
PRESS RELEASE

published on 07/28/2025 at 22:15, 10 months 24 days ago

Abivax annonce la réalisation de son offre au public de 747,5 millions de dollars
Abivax réalise une offre publique de 747,5 millions de dollars pour financer ses activités jusqu'en 2027. Cotée en bourse à Paris et Nasdaq, elle se concentre sur les maladies inflammatoires

Financement Abivax Bourse Offre Publique Maladies Inflammatoires
PRESS RELEASE

published on 07/28/2025 at 22:15, 10 months 24 days ago

Abivax Announces Closing of $747.5 Million Public Offering
Abivax announces closing of $747.5 million public offering, enabling financing into Q4 2027 and reaching planned milestones for Ulcerative Colitis. ADSs listed on Euronext Paris and Nasdaq Global Market

Abivax Ulcerative Colitis Nasdaq Finance Public Offering
BRIEF

published on 07/25/2025 at 08:05, 10 months 28 days ago

Abivax Raises $747.5M Through ADS Offering

Biotechnology Abivax Nasdaq Capital Increase ADS Offering
BRIEF

published on 07/25/2025 at 08:05, 10 months 28 days ago

Abivax lève 747,5 millions de dollars grâce à une offre publique d'achat (ADS)

Biotechnologie Abivax Nasdaq Augmentation De Capital Offre ADS
PRESS RELEASE

published on 07/25/2025 at 08:00, 10 months 28 days ago

Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l'Offre à 747,5 M$ (637,5 M€)
Abivax annonce exercice intégral option souscription ADS supplémentaires. Produit brut Offre à 747,5 M$. Société biotechnologie spécialisée en immunothérapie. Prix offre 64,00$ par ADS. Actions admises Nasdaq et Euronext. Document relatif déposé auprès de la SEC

Biotechnologie Abivax SEC Immunothérapie Prix Offre
PRESS RELEASE

published on 07/25/2025 at 08:00, 10 months 28 days ago

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
Abivax announces full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5M (€637.5M). Company to apply net proceeds to identified use of funds

Abivax Underwriters ADSs Offering Proceeds

Published on 06/22/2026 at 15:58, 3 hours 8 minutes ago

Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 3 hours 36 minutes ago

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 4 hours 6 minutes ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 5 hours 5 minutes ago

Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 5 hours 6 minutes ago

Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner

View all ACCESSWIRE

Published on 06/22/2026 at 18:54, 12 minutes ago

EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:30, 36 minutes ago

Amprion welcomes RWE’s entry into M31
Published on 06/22/2026 at 18:30, 36 minutes ago

Avolta awarded 10-year contract at Orlando International Airport across travel retail and F&B
Published on 06/22/2026 at 18:05, 1 hour 1 minute ago

Bybit EU Strengthens European Positioning Ahead of MiCAR Transition
Published on 06/22/2026 at 18:00, 1 hour 6 minutes ago

Zendure Unveils the ZEN+ HOME AI Energy Ecosystem at Intersolar 2026

View all EQS

Published on 06/22/2026 at 18:45, 21 minutes ago

Governance evolution
Published on 06/22/2026 at 18:45, 21 minutes ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 49 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 49 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 1 hour 6 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News